// App-Quantinova.ai

ABS003 : CONCOMITANT USE OF ADVATE® AND EMICIZUMAB IN PATIENTS WITH HAEMOPHILIA A: RESULTS AND ANALYSIS FROM A UK NEQAS BC EMICIZUMAB EXERCISE

Researchers

Presenter

  • I. Jennings

Principal Investigators

  • N/A

Medical Centers

  • UKNEQAS, Sheffield, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hemophilia

Biomarkers

  • Activated partial thromboplastin time

Drug/Treatment

  • Advate

  • FVIII

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved